Hints and tips:
...CVS Health, the largest pharmacy chain in the US, in 2018 acquired Aetna for $69bn and Cigna combined with Express Scripts in a $67bn deal, including debt....
...Unlike Humana, CVS Health also offers pharmacy, retail and healthcare services. The group reported that revenue grew about 12 per cent to $93.8bn....
...Humana and Cigna together made about $263bn. Both Cigna and Humana have had previous deals blocked by federal courts....
...“Is the biosimilar market a failure with respect to these pharmacy benefit drugs like Humira?...
Japan is a pioneer of combining retail outlets with pharmacies and support services for ageing shoppers
...Humana on Friday became the latest to warn on rising costs....
...One thing to start: Cigna is in talks to merge with Humana in a deal that would create a US health insurance giant worth $140bn and provide a significant test for antitrust authorities, according to people...
...Brewer, one of the few African-American women to run a company in the S&P 500, arrived as pharmacy chains were being boosted by the strong early uptake of Covid-19 vaccines....
...News round-up General Atlantic takes first step towards potential US listing (FT) Cigna pulls out of blockbuster deal to create insurance giant with Humana (FT) Occidental Petroleum agrees $12bn deal...
...It also restored the Paris Theater in New York, preventing it from suffering the indignity of being turned into a chain pharmacy....
...Same-store sales at its pharmacies, however, rose 9.8 per cent ahead of estimates of 8.8 per cent, partly thanks to higher prices....
...The FTC’s detailed opposition to the Horizon deal focuses on so-called pharmacy benefit managers. These businesses determine which drug prescriptions are eligible for health insurance reimbursement....
...The FTC had contended that Amgen could get buyers such as health insurers or pharmacy benefit managers to favour Horizon’s drugs by bundling them with its own best-selling medicines....
...Its — untested — argument is that Amgen could use rebates on its blockbusters to encourage insurers and pharmacy benefit managers to favour Horizon’s drugs....
...However, the FTC’s case against Amgen is targeted at the power the company allegedly wields more broadly with health insurers and middlemen in the US healthcare system, known as pharmacy benefit managers...
...US health officials last week warned that some pharmacies were running out of storage space for the drug just weeks after distribution began because of tepid demand....
...The FTC argued that Amgen could use the rebates it pays on its “blockbuster” drugs to press insurance companies and pharmacy benefit managers into paying for two of Horizon’s medicines: Tepezza for an autoimmune...
...It required the six largest pharmacy benefit managers, which negotiate fees and rebates with drug manufacturers, to share information on their business practices....
...Amgen said it would offer its biologic treatment, named Amjevita, to US health insurers and middlemen known as pharmacy benefit managers through two pricing plans....
...In 2014 it bought the Co-operative Group’s pharmacy business for £620mn....
...That was despite pharmacy sales falling almost 7 per cent as demand slipped for Covid-19 services such as vaccines....
...The firm has taken on companies such as health insurance group Humana and department store operator Kohl’s....
...The Future Fund has also taken stakes in advanced materials group Oxford Nanosystems, biotech firm Roslin Technologies, online pharmacy Phlo Technologies, Magnitude Biosciences, a life sciences company,...
...Since then the ecommerce giant has focused on expanding its other healthcare offerings, including an online pharmacy and telehealth services....
...This includes a large pharmacy benefit management business and a leading health insurance division. Walgreens remains overly dependent on its nearly 9,000 stores in the US....
International Edition